Charles Piller

637 total citations
34 papers, 374 citations indexed

About

Charles Piller is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Pharmacology. According to data from OpenAlex, Charles Piller has authored 34 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 6 papers in Reproductive Medicine and 3 papers in Pharmacology. Recurrent topics in Charles Piller's work include Science, Research, and Medicine (6 papers), Health and Medical Research Impacts (3 papers) and Biomedical Ethics and Regulation (2 papers). Charles Piller is often cited by papers focused on Science, Research, and Medicine (6 papers), Health and Medical Research Impacts (3 papers) and Biomedical Ethics and Regulation (2 papers). Charles Piller collaborates with scholars based in Netherlands. Charles Piller's co-authors include John Travis, W. Kip Viscusi, Douglas Easterling and Jennifer Couzin-Frankel and has published in prestigious journals such as Science, Journal of Policy Analysis and Management and Medical Entomology and Zoology.

In The Last Decade

Charles Piller

29 papers receiving 339 citations

Peers

Charles Piller
David Mundy United States
Jasmin Divers United States
Aaron A. Sorensen United States
Alison M. Devlin United Kingdom
Charles Piller
Citations per year, relative to Charles Piller Charles Piller (= 1×) peers Anne-Marie Tassé

Countries citing papers authored by Charles Piller

Since Specialization
Citations

This map shows the geographic impact of Charles Piller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Piller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Piller more than expected).

Fields of papers citing papers by Charles Piller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Piller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Piller. The network helps show where Charles Piller may publish in the future.

Co-authorship network of co-authors of Charles Piller

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Piller. A scholar is included among the top collaborators of Charles Piller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Piller. Charles Piller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piller, Charles. (2024). ‘Damning’ FDA inspection report undermines Alzheimer’s drug. Science. 383(6688). 1165–1166.
2.
Piller, Charles. (2024). Firm misled investors on Alzheimer’s drug, SEC charges. Science. 386(6717). 15–15.
3.
Piller, Charles. (2024). Authors move to retract discredited Alzheimer’s study. Science. 384(6700). 1055–1055. 1 indexed citations
4.
Piller, Charles. (2023). Report on trial death stokes Alzheimer’s drug fears. Science. 380(6641). 122–123. 7 indexed citations
5.
Piller, Charles. (2022). Research backing experimental Alzheimer’s drug was first target of suspicion. Science. 377(6604). 363–363. 3 indexed citations
6.
Piller, Charles. (2022). Failing the test. Science. 375(6580). 484–489. 1 indexed citations
7.
Piller, Charles. (2022). Blots on a field?. Science. 377(6604). 358–363. 84 indexed citations
8.
Piller, Charles. (2022). Research backing experimental Alzheimer’s drug was first target of suspicion. Science. 377(6604). 363–363. 3 indexed citations
9.
Piller, Charles. (2021). Many scientists citing two scandalous COVID-19 papers ignore their retractions. Science. 11 indexed citations
10.
Piller, Charles. (2020). Undermining CDC. Science. 370(6515). 394–399. 4 indexed citations
11.
Piller, Charles & John Travis. (2020). Authors, elite journals under fire after major retractions. Science. 368(6496). 1167–1168. 17 indexed citations
13.
Piller, Charles. (2020). Official inaction. Science. 370(6512). 24–29. 1 indexed citations
14.
Piller, Charles. (2019). Dubious diagnosis. Science. 363(6431). 1026–1031. 25 indexed citations
15.
Piller, Charles. (2019). FDA enforcement actions plummet under Trump. Science. 365(6448). 12–13. 4 indexed citations
16.
Piller, Charles. (2019). Double dip. Science. 366(6468). 941–943. 1 indexed citations
17.
Piller, Charles. (2018). At arm's length. Science. 362(6419). 1100–1103. 1 indexed citations
18.
Piller, Charles. (2018). Is FDA's revolving door open too wide?. Science. 361(6397). 21–21. 7 indexed citations
19.
Easterling, Douglas, et al.. (1993). The Fail-Safe Society: Community Defiance and the End of American Technological Optimism. Journal of Policy Analysis and Management. 12(4). 794–794. 31 indexed citations
20.
Piller, Charles. (1991). The Fail-Safe Society: Community Defiance and the End of American Technological Optimism. Medical Entomology and Zoology. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026